GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Coloplast A/S COLO B.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

496.70

-2.26%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

27 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 6Strong buy
  • 3Buy
  • 16Hold
  • 2Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 496.70Average target 658.22

Low
546.41
Average
658.22
Median
642.60
High
840.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029FY2030FY2031
RevenueDKK 30.78bnDKK 33.51bnDKK 35.92bnDKK 38.53bnDKK 40.73bn
Revenue, highestDKK 31.33bnDKK 36.16bnDKK 38.48bnDKK 41.48bnDKK 42.84bn
Revenue, lowestDKK 30.37bnDKK 31.42bnDKK 33.60bnDKK 35.92bnDKK 39.07bn
Earnings per share26.0631.5633.7136.68—
Earnings per share, highest28.3736.5037.2841.07—
Earnings per share, lowest24.0028.8831.0633.31—
Analysts203332

Earnings against forecasts

Earnings per share by fiscal quarter

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Forecast6.106.325.075.135.775.866.025.88
Reported6.204.673.864.344.895.845.665.57
Difference+1.6%-26.1%-23.9%-15.4%-15.3%-0.3%-6.0%-5.3%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

9 / 10

Revenue growth 7.2% a year over 10 years. Return on equity 22.6%.

Model fair value

781.61

From earnings 781.61, from revenue 707.58.

Piotroski score

4 / 9

A nine-point test of financial strength, for 30 Sept 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.